Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy

被引：0
|
作者：
Radosavljevic, D. Z. [1 ]
Gavrilovic, D. [1 ]
Golubicic, I. [1 ]
Jelic, S. [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18046
引用
收藏
页数：1
相关论文
共 50 条
  • [31] XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy
    Zou, H. Z.
    Zhao, Y. Q.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 500 - 506
  • [32] Prognostic value of CTCs in advanced NSCLC patients treated with platinum-based chemotherapy
    Calabuig-Farinas, S.
    Muinelo-Romay, L.
    Abalo, A.
    Lago, R.
    Mosqueda, M.
    Rodriguez Lopez, C.
    Escorihuela, E.
    Gallach Garcia, S.
    Garcia, J.
    Blasco, A.
    Jantus-Lewintre, E.
    Lopez, R.
    Camps, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] Predictive and prognostic value of KRAS mutations in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy
    Mellema, Wouter W.
    Dingemans, Anne-Marie C.
    Smit, Egbert F.
    Derks, Jules
    Heideman, Danielle A. M.
    van Suylen, Robertjan
    Thunnissen, Frederik B.
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [34] Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Lima, Aurea
    Seabra, Vitor
    Martins, Sandra
    Coelho, Ana
    Araujo, Antonio
    Medeiros, Rui
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (05) : 3349 - 3357
  • [35] Thymidylate synthase polymorphisms are associated to therapeutic outcome of advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Aurea Lima
    Vítor Seabra
    Sandra Martins
    Ana Coelho
    António Araújo
    Rui Medeiros
    Molecular Biology Reports, 2014, 41 : 3349 - 3357
  • [36] Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study
    Joshi, Amit
    Kate, Shruti
    Noronha, Vanita
    Patil, Vijay
    Trivedi, Vaishakhi
    Goud, Supriya
    More, Sucheta
    Bhairva, Sandeep
    Prabhash, Kumar
    ECANCERMEDICALSCIENCE, 2018, 12
  • [37] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy:: FISH results.
    Felip, E.
    Rojo, F.
    Reck, M.
    Heller, A.
    Klughammer, B.
    Maacke, H.
    Möcks, J.
    Brennscheidt, U.
    Gatzemeier, U.
    Baselga, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 404S - 404S
  • [38] Evaluation of weight gain and overall survival of patients with advanced non-small cell lung cancer (NSCLC) treated with first-line platinum-based chemotherapy.
    Roeland, Eric
    Fintelmann, Florian J.
    Hilton, Fiona
    Tarasenko, Lisa
    Calle, Roberto A.
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [39] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Hirotsugu Kenmotsu
    Tateaki Naito
    Keita Mori
    Ryo Ko
    Akira Ono
    Kazushige Wakuda
    Hisao Imai
    Tetsuhiko Taira
    Haruyasu Murakami
    Masahiro Endo
    Toshiaki Takahashi
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 521 - 526
  • [40] Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Mori, Keita
    Ko, Ryo
    Ono, Akira
    Wakuda, Kazushige
    Imai, Hisao
    Taira, Tetsuhiko
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 521 - 526
12345